Release Date: 23/11/12 18:25 Summary: Results of Annual General Meeting Price Sensitive: No Download Document 293.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%